Payments to Acquire Property, Plant, and Equipment of Perspective Therapeutics, Inc. from 30 Sep 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Perspective Therapeutics, Inc. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 30 Sep 2010 to 31 Dec 2025.
  • Perspective Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $4,656,000, a 49% decline year-over-year.
  • Perspective Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $12,749,000, a 77% decline from 2024.
  • Perspective Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $54,414,000, a 4976% increase from 2023.
  • Perspective Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $1,072,000, a 280% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

Perspective Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $12,749,000 -$41,665,000 -77% 01 Jan 2025 31 Dec 2025 10-K 16 Mar 2026 2025 FY
2024 $54,414,000 +$53,342,000 +4976% 01 Jan 2024 31 Dec 2024 10-K 16 Mar 2026 2025 FY
2023 $1,072,000 +$790,000 +280% 01 Jan 2023 31 Dec 2023 10-K/A 28 Mar 2025 2024 FY
2022 $282,000 -$99,000 -26% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $381,000 +$108,000 +40% 01 Jul 2020 30 Jun 2021 10-KT 01 May 2023 2023 Q1
2020 $273,000 -$171,000 -39% 01 Jul 2019 30 Jun 2020 10-KT 01 May 2023 2023 Q1
2019 $444,000 +$107,000 +32% 01 Jul 2018 30 Jun 2019 10-K 27 Sep 2021 2021 FY
2018 $337,000 -$212,000 -39% 01 Jul 2017 30 Jun 2018 10-K 25 Sep 2020 2020 FY
2017 $549,000 +$70,000 +15% 01 Jul 2016 30 Jun 2017 10-K 27 Sep 2019 2019 FY
2016 $479,000 +$346,000 +260% 01 Jul 2015 30 Jun 2016 10-K 26 Sep 2018 2018 FY
2015 $133,000 +$113,971 +599% 01 Jul 2014 30 Jun 2015 10-K 28 Sep 2017 2017 FY
2014 $19,029 +$12,453 +189% 01 Jul 2013 30 Jun 2014 10-K 09 Sep 2016 2016 FY
2013 $6,576 -$48,481 -88% 01 Jul 2012 30 Jun 2013 10-K 14 Sep 2015 2015 FY
2012 $55,057 -$82,439 -60% 01 Jul 2011 30 Jun 2012 10-K 30 Sep 2013 2013 FY
2011 $137,496 01 Jul 2010 30 Jun 2011 10-K/A 26 Oct 2012 2012 FY

Perspective Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,656,000 -$4,416,000 -49% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q1 2024 $9,072,000 +$8,871,000 +4413% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q1 2023 $201,000 +$175,000 +673% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q3 2022 $90,000 +$36,000 +67% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022 2023 Q1
Q1 2022 $26,000 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 $54,000 -$59,000 -52% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q1
Q3 2020 $113,000 +$15,000 +15% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021 2022 Q1
Q3 2019 $98,000 -$16,000 -14% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020 2021 Q1
Q3 2018 $114,000 +$60,000 +111% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019 2020 Q1
Q3 2017 $54,000 -$93,000 -63% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018 2019 Q1
Q3 2016 $147,000 +$143,000 +3575% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2018 Q1
Q3 2015 $4,000 -$3,453 -46% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2017 Q1
Q3 2014 $7,453 +$5,412 +265% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015 2016 Q1
Q3 2013 $2,041 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014 2015 Q1
Q3 2011 $6,795 +$4,903 +259% 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012 2013 Q1
Q3 2010 $1,892 01 Jul 2010 30 Sep 2010 10-Q/A 13 Dec 2011 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.